Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPERnICOS: Eosinophil-guided Reduction of Inhaled Corticosteroids and Azithromycin in Severe COPD
2020-003014-12Phase 4Active
- Sponsor
- COPD360Net
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of azithromycin in chronic obstructive pulmonary disease (COPD), sponsored by COPD360Net. Primary endpoint: Primary endpoint for inhaled corticosteroids and azithromycin. Started Jul 2020; status: active.
02
Drugs
azithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2020-003014-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003014-12.